Stryker Spine — Net Sales increased by 20.0% to $12.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 98.0%, from $608.00M to $12.00M. Over 2 years (FY 2021 to FY 2023), Spine — Net Sales shows relatively stable performance with a 0.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growing market share or higher procedural volumes in spinal surgery, while a decrease may signal competitive pressure, pricing erosion, or a decline in elective spinal procedure volumes.
This metric represents the total revenue generated from the sale of spinal implant devices, including hardware and instr...
Peers in the medical device sector report similar revenue streams under 'Spine' or 'Neuroscience' segments, often benchmarked against total orthopedic market growth rates.
syk_segment_spinal_implants_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $614.00M | $564.00M | $600.00M | $558.00M | $580.00M | $560.00M | $594.00M | $568.00M | $592.00M | $582.00M | $636.00M | $600.00M | $614.00M | $608.00M | $332.00M | $10.00M | $12.00M |
| QoQ Change | — | -8.1% | +6.4% | -7.0% | +3.9% | -3.4% | +6.1% | -4.4% | +4.2% | -1.7% | +9.3% | -5.7% | +2.3% | -1.0% | -45.4% | -97.0% | +20.0% |
| YoY Change | — | — | — | — | -5.5% | -0.7% | -1.0% | +1.8% | +2.1% | +3.9% | +7.1% | +5.6% | +3.7% | +4.5% | -44.7% | -98.4% | -98.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.